Lv1
90 积分 2022-12-06 加入
Opportunities and hurdles to European market access for multi-herbal traditional Chinese medicine products: An analysis of EU regulations for combination herbal medicinal products
6个月前
已完结
Les médicaments hybrides en France. Genèse des médicaments hybrides et cadre règlementaire en Europe et en France
1年前
已完结
Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumab
1年前
已完结
Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines Agency
1年前
已完结
[EMA approval procedures and assessment of innovation by AIFA: a cross sectional analysis.]
1年前
已关闭
Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents
1年前
已完结
Transforming Evidence Generation for Drug Label Changes: A Case Study
1年前
已完结
The NBER Orange Book Dataset: A user's guide
1年前
已完结
Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance
1年前
已完结
Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
1年前
已完结
皖公网安备34019202002308
